News TME Pharma N.V.

Equities

ALTME

NL0015000YE1

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 12:55:00 2026-03-10 pm EDT			5-day change	1st Jan Change
0.0763 ^EUR	+2.83%		+5.83%	+17.02%

Mar. 09	TME Pharma Secures 12-month Loan Extension	MT
Jan. 05	TME Pharma N.V. Provides Update on Its Activities	CI

All News

Mar. 09	TME Pharma Secures 12-month Loan Extension	MT
Mar. 09	TME Pharma extends financial runway to over 12 months	GL
Jan. 05	TME Pharma N.V. Provides Update on Its Activities	CI
Jan. 05	TME Pharma provides update on its activities	GL
Nov. 17	TME Pharma N.V. Announces Extension of Certain Bond Agreements	CI
Nov. 17	TME Pharma Lands Bonds Extension Approval From 29% Holders	MT
Nov. 17	TME Pharma announces receipt of agreements in principle to extend certain bond agreements	GL
Nov. 05	TME Pharma advances its new investment strategy and signs LOI with German resources company	GL
25-10-31	TME Pharma N : 2025, Half-Year Financial Report as of 30 June 2025	PU
25-10-30	TME Pharma publishes its semi annual results and half-year report	GL
25-10-29	TME Pharma N.V. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-09-22	TME Pharma Announces Date of Publication of Half Year Results and CEO Share Purchase	BU
25-09-01	TME Pharma Completes August Financing and Publishes Cash Position	BU
25-08-27	TME Pharma N.V. announced that it has received ?0.5 million in funding	CI
25-08-25	TME Pharma Plans Bond Issue to Boost Financial Capacity	MT
25-08-25	TME Pharma to raise €500k through new bond issue and receives new notice of shareholding	BU
25-08-24	TME Pharma N.V. announced that it expects to receive ?0.5 million in funding	CI
25-07-29	TME Pharma Provides Update About Additional Strategy	BU
25-07-08	TME Pharma: Termination of the Liquidity Contract	BU
25-06-30	TME Pharma Announces New Treasury Investment Policy	BU
25-06-27	TME Pharma Provides Results of Final Exercise of Warrants Z	BU
25-06-25	TME Pharma N.V. Approves Appointment of Diede Van Den Ouden as Chief Executive Officer	CI
25-06-25	Tme Pharma N.V. Appoints Diede Mink Van Den Ouden as Sole Member of the Board of Directors	CI
25-06-25	TME Pharma Appoints Diede van den Ouden as New CEO at the 2025 Annual General Meeting of Shareholders	BU
25-06-18	TME Pharma N.V. Announces Successful Next Step in Its NOX-E36 Ophthalmology Strategy with Signature of Option Framework Agreement with Singapore Eye Research Institute	CI